Cybersecurity

The digital security of healthcare institutions and data is a growing concern, with an increasing number of cyberattacks each year against healthcare systems, which are seen as easy targets. Cyber attacks often use ransomware to target personal health information, patient data and medical devices to cut off access to the data until a ransom is payed to the hacker. Cybercriminals have become more sophisticated, using malware, ransomware and spyware to attack outdated and vulnerable systems and software. Due to the interconnected nature of hospital IT systems today, the weakest link can be older web-enabled medical devices, including clinical and non-clinical systems. Employees are also a major target of attacks via malicious e-mails that prompt them to open attachments that then download malware onto the hospital's IT system.

AHIMA: Expect widespread effects of ICD-10 delay

According to an article published in the Journal of the American Health Information Management Association, the ICD-10 implementation deadline impacts all sectors of the healthcare industry.

AHIMA establishes new Grace award

The American Health Information Management Association (AHIMA) has established a new award to recognize outstanding and innovative approaches to health information management (HIM).

Payors, associations team to issue new PHR guides

Healthcare organizations are teaming up to help take the mystery out of using personal health records (PHRs) by rolling out two new informational brochures to help promote the understanding and use of PHRs among consumers and clinicians. 

AHIMA offers new copy, transcription toolkits

The American Health Information Management Association (AHIMA) is offering a Copy Functionality Toolkit eBook and Transcription Toolkit eBook to help health information management leaders develop practices that will ensure the quality of information in a health record.

Privacy & Security: Playing Catch Up

Were entering a new era of increased enforcement of HIPAA rules and regulationsare you ready? Audits are only going to increase and new vulnerabilities crop up all the time. CMIOs need to know about risk assessment, training, managing the use of mobile devices and more to keep their organizations compliant and their patient data secure.

AHIMA recommends providers keep working on ICD-10 implementation

The American Health Information Management Association (AHIMA) urged the healthcare community to continue preparing for the transition to the ICD-10 classification system, warning that the U.S. Congress may not act on requests to stop ICD-10 implementation and let stakeholders design and adopt a new classification system to replace ICD-9-CM.

HIMSS: Hospitals will have to shell out millions for ICD conversion

While organizations are planning for the mandatory transition to the ICD-10 code set, many have wondered what the financial implications will be. Now, they may be wishing that they were still wondering about financial implications after the Centers for Medicare & Medicaid Services (CMS) estimated that the total costs associated with the ICD-10 conversion may reach $640 million in 2013 alone. These estimates were presented during a HIMSS Virtual Briefing Oct. 12.

AHIMA: ICD-11 on horizon, but providers must get through ICD-10 first

SALT LAKE CITYManaging information in the 21st century and outlining how hospitals can gear up to make the transition to ICD-10 codes was the keynote address presented Oct. 4 at the American Health Information Management Association (AHIMA) conference by T. Bedirhan Ustun, MD, PhD, team coordinator of classification, terminology and standards in the department of health statistics at the World Health Organization (WHO).

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.